Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process

{
  "id": "008220-2026",
  "tag": [
    "award",
    "contract"
  ],
  "bids": {
    "statistics": [
      {
        "id": "1",
        "value": 5,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "2",
        "value": 5,
        "measure": "bids",
        "relatedLot": "1"
      },
      {
        "id": "3",
        "value": 4,
        "measure": "bids",
        "relatedLot": "2"
      },
      {
        "id": "4",
        "value": 4,
        "measure": "bids",
        "relatedLot": "2"
      },
      {
        "id": "5",
        "value": 4,
        "measure": "bids",
        "relatedLot": "3"
      },
      {
        "id": "6",
        "value": 4,
        "measure": "bids",
        "relatedLot": "3"
      }
    ]
  },
  "date": "2026-01-29T16:42:14Z",
  "ocid": "ocds-h6vhtk-0428bb",
  "buyer": {
    "id": "GB-FTS-130973",
    "name": "NHS England"
  },
  "awards": [
    {
      "id": "008220-2026-1",
      "title": "Lot 1 - Hub",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-8874",
          "name": "University College London Hospitals NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "1"
      ]
    },
    {
      "id": "008220-2026-2",
      "title": "Lot 1 - Hub",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-173038",
          "name": "NHS Lothian"
        }
      ],
      "relatedLots": [
        "1"
      ]
    },
    {
      "id": "008220-2026-3",
      "title": "Lot 2 - Tissue Establishment",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-8874",
          "name": "University College London Hospitals NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "2"
      ]
    },
    {
      "id": "008220-2026-4",
      "title": "Lot 2 - Tissue Establishment",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-173039",
          "name": "Scottish National Blood Transfusion Service"
        }
      ],
      "relatedLots": [
        "2"
      ]
    },
    {
      "id": "008220-2026-5",
      "title": "Lot 3 - Fertility & Endocrine Restoration Services",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-8874",
          "name": "University College London Hospitals NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "3"
      ]
    },
    {
      "id": "008220-2026-6",
      "title": "Lot 3 - Fertility & Endocrine Restoration Services",
      "status": "active",
      "suppliers": [
        {
          "id": "GB-FTS-21063",
          "name": "Guy's and St Thomas' NHS Foundation Trust"
        }
      ],
      "relatedLots": [
        "3"
      ]
    }
  ],
  "tender": {
    "id": "C371608",
    "lots": [
      {
        "id": "1",
        "title": "Lot 1 - Hub",
        "status": "cancelled",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year<br/>contract period."
        },
        "hasOptions": true,
        "description": "As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 1 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3: <br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Key Criteria",
              "type": "quality",
              "description": "57"
            },
            {
              "name": "Social Value - Key Criteria",
              "type": "quality",
              "description": "10"
            },
            {
              "name": "Value - Key Criteria",
              "type": "cost",
              "description": "33"
            }
          ]
        }
      },
      {
        "id": "2",
        "title": "Lot 2 - Tissue Establishment",
        "status": "cancelled",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year<br/>contract period."
        },
        "hasOptions": true,
        "description": "As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public<br/>Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 2 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3:<br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Social Value - Key Criteria",
              "type": "quality",
              "description": "10"
            },
            {
              "name": "Remaining Key Criteria",
              "type": "quality",
              "description": "57"
            },
            {
              "name": "Value - Key Criteria",
              "type": "cost",
              "description": "33"
            }
          ]
        }
      },
      {
        "id": "3",
        "title": "Lot 3 - Fertility & Endocrine Restoration Service",
        "status": "cancelled",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year<br/>contract period."
        },
        "hasOptions": true,
        "description": "As detailed in the Competitive Process documentation.<br/>This is a Provider Selection Regime (PSR)Contract Notice. The awarding of this contract<br/>is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For<br/>the avoidance of doubt, the provisions of the Public<br/>Contracts Regulations 2015 do not apply to this award.<br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/>The intention is to award contracts using the Competitive Process.<br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning<br/>and contracting of this service. NHS England continues to exist as a statutory body for<br/>now. The dissolution of NHS England during the term of the contract will be subject to an<br/>act of Parliament and its undertakings will be transferred as appropriate. As and when<br/>NHS England is dissolved, commissioning responsibilities will be transferred to an<br/>alternative commissioning authority. At this time, the General Condition 12 ‘Assignment<br/>and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the<br/>commissioner, will set out the terms and conditions under which the contract will be<br/>transferred or assigned to the relevant commissioning authority.<br/>Please note the value included at V.2.4.1 is the initial Lot 3 contract value over the whole contract period including extensions. The values included under the individual awarded providers are for the initial contract period of 5 years only. Additional information: This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 10th February 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the competitive process of the PSR. Written representations should be sent to anna.salt@nhs.net ensuring the following details are referenced:<br/>Project reference: C371608<br/>Project title: Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process<br/>This decision has been made as per NHS England governance processes, by the National Commissioning<br/>Group on 20th January 2026. No conflicts of Interest were identified amongst decision<br/>makers.<br/>Key Criteria were weighted as follows:<br/>Lot 1:<br/>• Quality & Innovation 27%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 8%<br/>• Social Value 10%<br/><br/>Lot 2:<br/>• Quality & Innovation 42%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 13%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%<br/><br/>Lot 3:<br/>• Quality & Innovation 33%<br/>• Value 33%<br/>• Integration, Collaboration & Service Sustainability 22%<br/>• Improving Access, Reducing Health Inequalities and Facilitating Choice 2%<br/>• Social Value 10%",
        "awardCriteria": {
          "criteria": [
            {
              "name": "Social Value - Key Criteria",
              "type": "quality",
              "description": "10"
            },
            {
              "name": "Remaining Key Criteria",
              "type": "quality",
              "description": "57"
            },
            {
              "name": "Value - Key Criteria",
              "type": "cost",
              "description": "33"
            }
          ]
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process",
    "status": "complete",
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf<br/>of NHS England (referred to as the Authority), is inviting suitably qualified and<br/>experienced providers to respond to this Competitive Process for the provision of a<br/>Fertility service for preservation and use of reproductive tissue for service users who<br/>cannot store mature eggs/sperm who are at high/very high risk of infertility.<br/>* Lot 1 - Hub - (2 providers - 1 provider to cover North East, North West, Yorkshire &<br/>Humber and Midlands NHS Regions and 1 provider to cover East of England, London,<br/>South East and South West NHS Regions)<br/>* Lot 2 - Tissue Establishment - (2 providers - 1 provider to cover North East, North West,<br/>Yorkshire & Humber and Midlands NHS Regions and 1 provider to cover East of England,<br/>London, South East and South West NHS Regions)<br/>* Lot 3 - Fertility & Endocrine Restoration Services (2 providers - 1 provider to cover North<br/>East, North West, Yorkshire & Humber and Midlands NHS Regions and 1 provider to<br/>cover East of England, London, South East and South West NHS Regions)<br/>The contract start date is 1st April 2026 with a service commencement date of no later than1st July 2026.<br/>The contract period is 5 years with Commissioners having the option to extend for up to a<br/>further 58 months.<br/>Please note that the contract value included in II.1.7.1 is the estimated contract value that was included in the contract notice and was based on the total contract period including optional extensions. The values included in the ‘suppliers awarded’ sections of individual notices are the intended contract award values over the initial contract period only and excludes any optional extension periods. All values are inclusive of VAT.",
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-130973",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKJ1",
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/",
        "buyerProfile": "https://www.england.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Anna Salt",
        "email": "anna.salt@nhs.net"
      }
    },
    {
      "id": "GB-FTS-8874",
      "name": "University College London Hospitals NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI",
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "University College London Hospitals NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-173038",
      "name": "NHS Lothian",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "NHS Lothian"
      }
    },
    {
      "id": "GB-FTS-173039",
      "name": "Scottish National Blood Transfusion Service",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKM",
        "locality": "Edinburgh",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Scottish National Blood Transfusion Service"
      }
    },
    {
      "id": "GB-FTS-21063",
      "name": "Guy's and St Thomas' NHS Foundation Trust",
      "roles": [
        "supplier"
      ],
      "address": {
        "region": "UKI",
        "locality": "London",
        "countryName": "United Kingdom"
      },
      "details": {
        "scale": "large"
      },
      "identifier": {
        "legalName": "Guy's and St Thomas' NHS Foundation Trust"
      }
    },
    {
      "id": "GB-FTS-141301",
      "name": "NHS Arden and Greater East Midlands Commissioning Support Unit",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "Derby",
        "postalCode": "DE1 3QT",
        "countryName": "United Kingdom",
        "streetAddress": "Cardinal Square, 10 Nottingham Road"
      },
      "details": {
        "url": "https://www.ardengemcsu.nhs.uk/"
      },
      "identifier": {
        "legalName": "NHS Arden and Greater East Midlands Commissioning Support Unit"
      }
    }
  ],
  "language": "en",
  "contracts": [
    {
      "id": "008220-2026-1",
      "title": "Lot 1 - Hub",
      "value": {
        "amount": 3347429,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-1",
      "dateSigned": "2026-01-20T00:00:00Z"
    },
    {
      "id": "008220-2026-2",
      "title": "Lot 1 - Hub",
      "value": {
        "amount": 2821756,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-2",
      "dateSigned": "2026-01-20T00:00:00Z"
    },
    {
      "id": "008220-2026-3",
      "title": "Lot 2 - Tissue Establishment",
      "value": {
        "amount": 4674978,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-3",
      "dateSigned": "2026-01-20T00:00:00Z"
    },
    {
      "id": "008220-2026-4",
      "title": "Lot 2 - Tissue Establishment",
      "value": {
        "amount": 4762905,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-4",
      "dateSigned": "2026-01-20T00:00:00Z"
    },
    {
      "id": "008220-2026-5",
      "title": "Lot 3 - Fertility & Endocrine Restoration Services",
      "value": {
        "amount": 2216662,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-5",
      "dateSigned": "2026-01-20T00:00:00Z"
    },
    {
      "id": "008220-2026-6",
      "title": "Lot 3 - Fertility & Endocrine Restoration Services",
      "value": {
        "amount": 1680393,
        "currency": "GBP"
      },
      "status": "active",
      "awardID": "008220-2026-6",
      "dateSigned": "2026-01-20T00:00:00Z"
    }
  ],
  "initiationType": "tender"
}

{
  "id": "040126-2025",
  "tag": [
    "tender"
  ],
  "date": "2025-07-15T15:48:29+01:00",
  "ocid": "ocds-h6vhtk-0428bb",
  "buyer": {
    "id": "GB-FTS-118033",
    "name": "NHS England"
  },
  "tender": {
    "id": "C371608",
    "lots": [
      {
        "id": "1",
        "title": "Lot 1 - Hub",
        "value": {
          "amount": 16498967,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year contract period."
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "NHS England has published three service specifications that describe an integrated single fertility preservation and restoration programme led by and co-ordinated through a Hub model arrangement.  The Hub is a hospital based clinical service and will provide a fertility preservation programme, coordination of service provision across services, leadership and advice.  <br/><br/>The requirements of this service are described in the specifications: <br/>https://www.england.nhs.uk/publication/service-specifications-fertility-preservation-and-restoration/ <br/><br/>The Hub also participates in and receives expert clinical and technical advice from a National Expert Group.  <br/><br/>This model has been designed to centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection surgery to take place in the service user’s local surgical treatment centre (Spoke).  The tissue is then processed, cryopreserved, and stored at an appointed Tissue Establishment licenced by the Human Tissue Authority. <br/><br/>The programme also covers the provision of fertility and endocrine restoration for service users who have cryopreserved ovarian tissue.  The programme does not currently include the restoration of testicular tissue as unlike ovarian tissue restoration, it is not currently clinically available for males. However, if this does become available over the life of the contract, it may be included by means of a contract modification. <br/><br/>The scope of the service is to commission an integrated, expert led fertility preservation and restoration programme for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility. The population covered by the service specifications include people who meet the eligibility criteria, supported by evidence.  Whilst the evidence is predominantly linked to children’s cancer and leukaemia onco fertility guidelines for patients receiving chemotherapy and radiotherapy, the Hub will be informed by similar guidelines for other service users and will receive diagnostic expert advice on these areas from the National Expert Group.  Given the specialised nature of this service, referrals from the devolved nations and further afield may also be received and accepted subject to appropriate commissioning arrangements and approvals. <br/><br/>This Competitive Process will compliment and be integrated with other fertility preservation programmes funded by NHS England.  <br/><br/>The Hub will provide the overall leadership to the integrated fertility programme.  The service model centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection via surgery to take place in the service user’s local surgical treatment centre, the spoke site. The Hub will work with the auto-transplantation sites to ensure referral pathways for use of ovarian tissue to restore fertility and endocrine function. <br/><br/>The Hub and associated Spokes will work with a designated Tissue Establishment (TE) that holds a Human Tissue Authority (HTA) Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue, to manage fertility preservation treatment by storage of reproductive tissue.<br/><br/>The Spoke sites will be located in hospital-based services which are Children and Young Adult Cancer Principal Treatment Centres / Bone Marrow Treatment (BMT) centres. The Hub and Spoke services will need to work with the designated TE to ensure the collection of the surgically removed tissue and transfer of the tissue to TE via a courier transport service is in accordance with the HTA licence requirements.  <br/><br/>The Tissue Establishment(s) must operate in compliance with the Human Tissue Authority Quality and Safety Standards and hold a Human Tissue Authority Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue.  <br/><br/>The Tissue Establishment will need to establish third party /Service Level Agreement (SLA) with the Hub, Spokes and Fertility Restoration Services.  <br/><br/>Fertility and endocrine restoration using cryopreserved ovarian tissue will need to be provided via ovarian tissue auto-transplantation surgery and will be undertaken in centres capable of the management and oversight of the auto-transplantation service. <br/><br/>Once the service is in place, compliance with the service specifications will be assessed via the quality surveillance assurance process as part of the Specialised Commissioning Quality Assurance & Improvement Framework. Standard formal reporting processes will commence from the agreed go live date and include quarterly submission of SSQD data.<br/><br/>The Hub and spoke elements of the fertility service will need to work with the Tissue Establishment to ensure that the fertility preservation treatment by cryopreservation of tissue is undertaken in compliance with HTA licence requirements. The Tissue Establishment will be subject to regular inspection by the HTA to ensure compliance of their work with HTA licence regulations.<br/><br/>Commissioned Providers must be able to demonstrate that they meet all aspects of the service specification for the Lots that they are intending to provide. <br/><br/>Commissioned Providers must be able to demonstrate that they can meet the demand for services in line with the service demand assumptions agreed with commissioners and that their capacity plan has sufficient flexibility to ensure patients primary treatment will not be delayed.<br/><br/>Interested parties may respond to this ITT in partnership with other organisations as part of a consortium, subject to them appointing a consortium lead to act on their behalf as the lead contracting party. The lead contracting party would take overall responsibility for delivery of the service(s) in accordance with the requirements of any future contract(s) if successful.<br/><br/>Please note that the contract values included in this notice are the estimated maximum available over the whole potential contract period (5 years + 58 months) and are inclusive of VAT.<br/><br/>To express interest and participate in the Competitive Process, please register and access documentation via the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome Should providers have any queries, or have problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk<br/><br/>A provider event via Microsoft Teams is planned for Tuesday 12th August 2025 at 3pm. If you would like to attend, please email anna.salt@nhs.net to register by 5pm on Monday 11th August 2025. All slides, questions<br/>and responses will be made available to all providers following this event via Atamis.<br/><br/>The response deadline is 12pm, noon, on Friday 26th September 2025 and the project reference in Atamis is C371608.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning and contracting of this service. NHS England continues to exist as a statutory body for now. The dissolution of NHS England during the term of the contract will be subject to an act of Parliament and its undertakings will be transferred as appropriate. As and when NHS England is dissolved, commissioning responsibilities will be transferred to an alternative commissioning authority. At this time, the General Condition 12 ‘Assignment and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the commissioner, will set out the terms and conditions under which the contract will be transferred or assigned to the relevant commissioning authority.",
        "contractPeriod": {
          "durationInDays": 1800
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "2",
        "title": "Lot 2 - Tissue Establishment",
        "value": {
          "amount": 20634320,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year contract period."
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "NHS England has published three service specifications that describe an integrated single fertility preservation and restoration programme led by and co-ordinated through a Hub model arrangement.  The Hub is a hospital based clinical service and will provide a fertility preservation programme, coordination of service provision across services, leadership and advice.  <br/><br/>The requirements of this service are described in the specifications: <br/>https://www.england.nhs.uk/publication/service-specifications-fertility-preservation-and-restoration/ <br/><br/>The Hub also participates in and receives expert clinical and technical advice from a National Expert Group.  <br/><br/>This model has been designed to centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection surgery to take place in the service user’s local surgical treatment centre (Spoke).  The tissue is then processed, cryopreserved, and stored at an appointed Tissue Establishment licenced by the Human Tissue Authority. <br/><br/>The programme also covers the provision of fertility and endocrine restoration for service users who have cryopreserved ovarian tissue.  The programme does not currently include the restoration of testicular tissue as unlike ovarian tissue restoration, it is not currently clinically available for males. However, if this does become available over the life of the contract, it may be included by means of a contract modification. <br/><br/>The scope of the service is to commission an integrated, expert led fertility preservation and restoration programme for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility. The population covered by the service specifications include people who meet the eligibility criteria, supported by evidence.  Whilst the evidence is predominantly linked to children’s cancer and leukaemia onco fertility guidelines for patients receiving chemotherapy and radiotherapy, the Hub will be informed by similar guidelines for other service users and will receive diagnostic expert advice on these areas from the National Expert Group.  Given the specialised nature of this service, referrals from the devolved nations and further afield may also be received and accepted subject to appropriate commissioning arrangements and approvals. <br/><br/>This Competitive Process will compliment and be integrated with other fertility preservation programmes funded by NHS England.  <br/><br/>The Hub will provide the overall leadership to the integrated fertility programme.  The service model centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection via surgery to take place in the service user’s local surgical treatment centre, the spoke site. The Hub will work with the auto-transplantation sites to ensure referral pathways for use of ovarian tissue to restore fertility and endocrine function. <br/><br/>The Hub and associated Spokes will work with a designated Tissue Establishment (TE) that holds a Human Tissue Authority (HTA) Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue, to manage fertility preservation treatment by storage of reproductive tissue.<br/><br/>The Spoke sites will be located in hospital-based services which are Children and Young Adult Cancer Principal Treatment Centres / Bone Marrow Treatment (BMT) centres. The Hub and Spoke services will need to work with the designated TE to ensure the collection of the surgically removed tissue and transfer of the tissue to TE via a courier transport service is in accordance with the HTA licence requirements.  <br/><br/>The Tissue Establishment(s) must operate in compliance with the Human Tissue Authority Quality and Safety Standards and hold a Human Tissue Authority Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue.  <br/><br/>The Tissue Establishment will need to establish third party /Service Level Agreement (SLA) with the Hub, Spokes and Fertility Restoration Services.  <br/><br/>Fertility and endocrine restoration using cryopreserved ovarian tissue will need to be provided via ovarian tissue auto-transplantation surgery and will be undertaken in centres capable of the management and oversight of the auto-transplantation service. <br/><br/>Once the service is in place, compliance with the service specifications will be assessed via the quality surveillance assurance process as part of the Specialised Commissioning Quality Assurance & Improvement Framework. Standard formal reporting processes will commence from the agreed go live date and include quarterly submission of SSQD data.<br/><br/>The Hub and spoke elements of the fertility service will need to work with the Tissue Establishment to ensure that the fertility preservation treatment by cryopreservation of tissue is undertaken in compliance with HTA licence requirements. The Tissue Establishment will be subject to regular inspection by the HTA to ensure compliance of their work with HTA licence regulations.<br/><br/>Commissioned Providers must be able to demonstrate that they meet all aspects of the service specification for the Lots that they are intending to provide. <br/><br/>Commissioned Providers must be able to demonstrate that they can meet the demand for services in line with the service demand assumptions agreed with commissioners and that their capacity plan has sufficient flexibility to ensure patients primary treatment will not be delayed.<br/><br/>Interested parties may respond to this ITT in partnership with other organisations as part of a consortium, subject to them appointing a consortium lead to act on their behalf as the lead contracting party. The lead contracting party would take overall responsibility for delivery of the service(s) in accordance with the requirements of any future contract(s) if successful.<br/><br/>Please note that the contract values included in this notice are the estimated maximum available over the whole potential contract period (5 years + 58 months) and are inclusive of VAT.<br/><br/>To express interest and participate in the Competitive Process, please register and access documentation via the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome Should providers have any queries, or have problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk<br/><br/>A provider event via Microsoft Teams is planned for Tuesday 12th August 2025 at 3pm. If you would like to attend, please email anna.salt@nhs.net to register by 5pm on Monday 11th August 2025. All slides, questions<br/>and responses will be made available to all providers following this event via Atamis.<br/><br/>The response deadline is 12pm, noon, on Friday 26th September 2025 and the project reference in Atamis is C371608.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning and contracting of this service. NHS England continues to exist as a statutory body for now. The dissolution of NHS England during the term of the contract will be subject to an act of Parliament and its undertakings will be transferred as appropriate. As and when NHS England is dissolved, commissioning responsibilities will be transferred to an alternative commissioning authority. At this time, the General Condition 12 ‘Assignment and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the commissioner, will set out the terms and conditions under which the contract will be transferred or assigned to the relevant commissioning authority.",
        "contractPeriod": {
          "durationInDays": 1800
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      },
      {
        "id": "3",
        "title": "Lot 3 - Fertility & Endocrine Restoration Service",
        "value": {
          "amount": 11060940,
          "currency": "GBP"
        },
        "status": "active",
        "options": {
          "description": "There is an option to extend for up to an additional 58 months following the initial 5 year contract period."
        },
        "hasOptions": true,
        "hasRenewal": false,
        "description": "NHS England has published three service specifications that describe an integrated single fertility preservation and restoration programme led by and co-ordinated through a Hub model arrangement.  The Hub is a hospital based clinical service and will provide a fertility preservation programme, coordination of service provision across services, leadership and advice.  <br/><br/>The requirements of this service are described in the specifications: <br/>https://www.england.nhs.uk/publication/service-specifications-fertility-preservation-and-restoration/ <br/><br/>The Hub also participates in and receives expert clinical and technical advice from a National Expert Group.  <br/><br/>This model has been designed to centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection surgery to take place in the service user’s local surgical treatment centre (Spoke).  The tissue is then processed, cryopreserved, and stored at an appointed Tissue Establishment licenced by the Human Tissue Authority. <br/><br/>The programme also covers the provision of fertility and endocrine restoration for service users who have cryopreserved ovarian tissue.  The programme does not currently include the restoration of testicular tissue as unlike ovarian tissue restoration, it is not currently clinically available for males. However, if this does become available over the life of the contract, it may be included by means of a contract modification. <br/><br/>The scope of the service is to commission an integrated, expert led fertility preservation and restoration programme for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility. The population covered by the service specifications include people who meet the eligibility criteria, supported by evidence.  Whilst the evidence is predominantly linked to children’s cancer and leukaemia onco fertility guidelines for patients receiving chemotherapy and radiotherapy, the Hub will be informed by similar guidelines for other service users and will receive diagnostic expert advice on these areas from the National Expert Group.  Given the specialised nature of this service, referrals from the devolved nations and further afield may also be received and accepted subject to appropriate commissioning arrangements and approvals. <br/><br/>This Competitive Process will compliment and be integrated with other fertility preservation programmes funded by NHS England.  <br/><br/>The Hub will provide the overall leadership to the integrated fertility programme.  The service model centralises the specialist fertility expertise in the Hub whilst enabling ovarian and testicular tissue collection via surgery to take place in the service user’s local surgical treatment centre, the spoke site. The Hub will work with the auto-transplantation sites to ensure referral pathways for use of ovarian tissue to restore fertility and endocrine function. <br/><br/>The Hub and associated Spokes will work with a designated Tissue Establishment (TE) that holds a Human Tissue Authority (HTA) Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue, to manage fertility preservation treatment by storage of reproductive tissue.<br/><br/>The Spoke sites will be located in hospital-based services which are Children and Young Adult Cancer Principal Treatment Centres / Bone Marrow Treatment (BMT) centres. The Hub and Spoke services will need to work with the designated TE to ensure the collection of the surgically removed tissue and transfer of the tissue to TE via a courier transport service is in accordance with the HTA licence requirements.  <br/><br/>The Tissue Establishment(s) must operate in compliance with the Human Tissue Authority Quality and Safety Standards and hold a Human Tissue Authority Human Application Sector Licence for reproductive tissue procurement, processing, testing, storage, distribution and disposal of tissue.  <br/><br/>The Tissue Establishment will need to establish third party /Service Level Agreement (SLA) with the Hub, Spokes and Fertility Restoration Services.  <br/><br/>Fertility and endocrine restoration using cryopreserved ovarian tissue will need to be provided via ovarian tissue auto-transplantation surgery and will be undertaken in centres capable of the management and oversight of the auto-transplantation service. <br/><br/>Once the service is in place, compliance with the service specifications will be assessed via the quality surveillance assurance process as part of the Specialised Commissioning Quality Assurance & Improvement Framework. Standard formal reporting processes will commence from the agreed go live date and include quarterly submission of SSQD data.<br/><br/>The Hub and spoke elements of the fertility service will need to work with the Tissue Establishment to ensure that the fertility preservation treatment by cryopreservation of tissue is undertaken in compliance with HTA licence requirements. The Tissue Establishment will be subject to regular inspection by the HTA to ensure compliance of their work with HTA licence regulations.<br/><br/>Commissioned Providers must be able to demonstrate that they meet all aspects of the service specification for the Lots that they are intending to provide. <br/><br/>Commissioned Providers must be able to demonstrate that they can meet the demand for services in line with the service demand assumptions agreed with commissioners and that their capacity plan has sufficient flexibility to ensure patients primary treatment will not be delayed.<br/><br/>Interested parties may respond to this ITT in partnership with other organisations as part of a consortium, subject to them appointing a consortium lead to act on their behalf as the lead contracting party. The lead contracting party would take overall responsibility for delivery of the service(s) in accordance with the requirements of any future contract(s) if successful.<br/><br/>Please note that the contract values included in this notice are the estimated maximum available over the whole potential contract period (5 years + 58 months) and are inclusive of VAT.<br/><br/>To express interest and participate in the Competitive Process, please register and access documentation via the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome Should providers have any queries, or have problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk<br/><br/>A provider event via Microsoft Teams is planned for Tuesday 12th August 2025 at 3pm. If you would like to attend, please email anna.salt@nhs.net to register by 5pm on Monday 11th August 2025. All slides, questions<br/>and responses will be made available to all providers following this event via Atamis.<br/><br/>The response deadline is 12pm, noon, on Friday 26th September 2025 and the project reference in Atamis is C371608.<br/><br/>This is a Provider Selection Regime (PSR) Contract Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.<br/><br/>The decision maker of the award will be: NHS England - National Commissioning Group.<br/><br/>The intention is to award a contracts using the Competitive Process.<br/><br/>The announcement by Government, on 13th March 2025, will not disrupt commissioning and contracting of this service. NHS England continues to exist as a statutory body for now. The dissolution of NHS England during the term of the contract will be subject to an act of Parliament and its undertakings will be transferred as appropriate. As and when NHS England is dissolved, commissioning responsibilities will be transferred to an alternative commissioning authority. At this time, the General Condition 12 ‘Assignment and Sub-Contracting’ of the NHS Standard Contract, as per the obligations of the commissioner, will set out the terms and conditions under which the contract will be transferred or assigned to the relevant commissioning authority.",
        "contractPeriod": {
          "durationInDays": 1800
        },
        "submissionTerms": {
          "variantPolicy": "notAllowed"
        }
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          },
          {
            "id": "85111000",
            "scheme": "CPV",
            "description": "Hospital services"
          },
          {
            "id": "85140000",
            "scheme": "CPV",
            "description": "Miscellaneous health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          },
          {
            "id": "85111000",
            "scheme": "CPV",
            "description": "Hospital services"
          },
          {
            "id": "85140000",
            "scheme": "CPV",
            "description": "Miscellaneous health services"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryAddresses": [
          {
            "region": "UK"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          },
          {
            "id": "85111000",
            "scheme": "CPV",
            "description": "Hospital services"
          },
          {
            "id": "85140000",
            "scheme": "CPV",
            "description": "Miscellaneous health services"
          }
        ]
      }
    ],
    "title": "Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility - Competitive Process",
    "value": {
      "amount": 48194228,
      "currency": "GBP"
    },
    "status": "active",
    "documents": [
      {
        "id": "economic",
        "documentType": "economicSelectionCriteria"
      },
      {
        "id": "technical",
        "documentType": "technicalSelectionCriteria"
      }
    ],
    "bidOpening": {
      "date": "2025-09-26T12:00:00+01:00"
    },
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "lotDetails": {
      "maximumLotsBidPerSupplier": null
    },
    "awardPeriod": {
      "startDate": "2025-09-26T12:00:00+01:00"
    },
    "description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England (referred to as the Authority), is inviting suitably qualified and experienced providers to respond to this Competitive Process for the provision of a Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility.<br/><br/>* Lot 1 - Hub - (2 providers - 1 provider to cover North East, North West, Yorkshire & Humber and Midlands NHS Regions and 1 provider to cover East of England, London, South East and South West NHS Regions) <br/><br/>* Lot 2 - Tissue Establishment - (2 providers - 1 provider to cover North East, North West, Yorkshire & Humber and Midlands NHS Regions and 1 provider to cover East of England, London, South East and South West NHS Regions) <br/><br/>* Lot 3 - Fertility & Endocrine Restoration Services (2 providers - 1 provider to cover North East, North West, Yorkshire & Humber and Midlands NHS Regions and 1 provider to cover East of England, London, South East and South West NHS Regions) <br/><br/>The service is due to commence on 1st April 2026 or sooner if possible.<br/><br/>The contract period is 5 years with Commissioners having the option to extend for up to a further 58 months.<br/><br/>Please note that the contract values included in this notice are the estimated maximum available over the whole potential contract period (5 years + 58 months) and are inclusive of VAT.  <br/><br/>To express interest and participate in the Competitive Process, please register and access documentation via the Atamis (Health Family) portal: https://atamis-1928.my.site.com/s/Welcome Should providers have any queries, or have problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk<br/><br/>A provider event via Microsoft Teams is planned for Tuesday 12th August 2025 at 3pm. If you would like to attend, please email anna.salt@nhs.net to register by 5pm on Monday 11th August 2025. All slides, questions<br/>and responses will be made available to all providers following this event via Atamis.<br/><br/>The response deadline is 12pm, noon, on Friday 26th September 2025 and the project reference in Atamis is C371608.",
    "tenderPeriod": {
      "endDate": "2025-09-26T12:00:00+01:00"
    },
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
    },
    "hasRecurrence": false,
    "classification": {
      "id": "85100000",
      "scheme": "CPV",
      "description": "Health services"
    },
    "submissionTerms": {
      "languages": [
        "en"
      ],
      "bidValidityPeriod": {
        "durationInDays": 120
      }
    },
    "submissionMethod": [
      "electronicSubmission",
      "written"
    ],
    "procurementMethod": "open",
    "mainProcurementCategory": "services",
    "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
    "procurementMethodDetails": "Open procedure"
  },
  "parties": [
    {
      "id": "GB-FTS-118033",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKE",
        "locality": "Leeds",
        "postalCode": "LS1 4AP",
        "countryName": "United Kingdom",
        "streetAddress": "7&8 Wellington Place"
      },
      "details": {
        "url": "https://www.england.nhs.uk//",
        "buyerProfile": "https://www.england.nhs.uk//",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "url": "https://health-family.force.com/s/Welcome",
        "name": "Anna Salt",
        "email": "anna.salt@nhs.net"
      }
    },
    {
      "id": "GB-FTS-130973",
      "name": "NHS England",
      "roles": [
        "reviewBody"
      ],
      "address": {
        "locality": "London",
        "postalCode": "SE1 8UG",
        "countryName": "United Kingdom",
        "streetAddress": "Wellington House, 133-135 Waterloo Rd"
      },
      "details": {
        "url": "https://www.england.nhs.uk/"
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "email": "england.commercialqueries@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}

{
  "id": "037497-2023",
  "tag": [
    "planning"
  ],
  "date": "2023-12-20T14:39:37Z",
  "ocid": "ocds-h6vhtk-0428bb",
  "buyer": {
    "id": "GB-FTS-67205",
    "name": "NHS England"
  },
  "tender": {
    "id": "ocds-h6vhtk-0428bb",
    "lots": [
      {
        "id": "1",
        "title": "Lot 1 - Hub covering North West, North East, Yorkshire & Humber and the Midlands",
        "status": "planned",
        "description": "As detailed in the PIN"
      },
      {
        "id": "2",
        "title": "Lot 2 - Hub covering East of England, London, South East and South West",
        "status": "planned",
        "description": "As detailed in the PIN."
      },
      {
        "id": "3",
        "title": "Lot 3 - Tissue Establishment - North West, North East, Yorkshire & Humber & Mids",
        "status": "planned",
        "description": "As detailed in the PIN."
      },
      {
        "id": "4",
        "title": "Lot 4 - Tissue Establishment East of England, London, SE and SW",
        "status": "planned",
        "description": "As detailed in the PIN."
      },
      {
        "id": "5",
        "title": "Lot 5 - Fertility and Endocrine Restoration Services NW, NE, Yorks and Humber",
        "status": "planned",
        "description": "As detailed in the PIN."
      },
      {
        "id": "6",
        "title": "Lot 6 - Fertility and Endocrine Restoration Services EoE, London, SE & SW",
        "status": "planned",
        "description": "As detailed in the PIN."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "2",
        "relatedLot": "2",
        "deliveryAddresses": [
          {
            "region": "UKH"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "3",
        "relatedLot": "3",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "4",
        "relatedLot": "4",
        "deliveryAddresses": [
          {
            "region": "UKH"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "5",
        "relatedLot": "5",
        "deliveryAddresses": [
          {
            "region": "UKD"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      },
      {
        "id": "6",
        "relatedLot": "6",
        "deliveryAddresses": [
          {
            "region": "UKH"
          }
        ],
        "additionalClassifications": [
          {
            "id": "85100000",
            "scheme": "CPV",
            "description": "Health services"
          }
        ]
      }
    ],
    "title": "Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very high risk of infertility",
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England Specialised Commissioning (referred to as the Commissioner), is undertaking a market engagement exercise to understand the current and future capacity and capability of the potential providers within this specialised area. Interested parties are encouraged to register their interest and participate in the market questionnaire which will provide feedback to commissioners. Please note that this is not a call for competition although the commissioner would encourage all potential providers to respond to this market engagement exercise.   <br/>NHS England would like to identify suitably qualified and experienced providers who are interested in being part of an integrated single fertility preservation service for people at high risk/very high risk of infertility and endocrine failure. <br/>A previous market engagement exercise was undertaken in February 2023 as part of the work to support the case for the service to attain NHSE commissioning which was confirmed in August 2023. <br/>The key objective of this Market Engagement process is to update the market with detail about the finalised proposed model for delivery and the requirements of the service specifications. This will enable commissioners to assess providers’ interest, capability and capacity to provide this Service(s) to serve the population of England. The population covered by the service specifications include people who meet the eligibility criteria, supported by evidence. Given the specialised nature of this service, referrals from the devolved nations and further afield may also be received and accepted subject to appropriate commissioning arrangements and approvals.<br/>The service will be delivered through an integrated hub and spoke model to support integrated service delivery. The Hub will be located in a hospital based clinical service and will provide the leadership, advice and co-ordination/monitoring for the overall fertility preservation programme. This model centralises the specialist fertility expertise in the Hub whilst enabling, ovarian and testicular tissue collection to take place in the service user’s surgical treatment centre (Spokes). The Hub and Spokes will work with a tissue establishment that can cryopreserve ovarian and testicular tissue with pathways into services that can provide fertility and endocrine restoration using cryopreserved ovarian tissue (but not for testicular tissue at this stage as this treatment is not yet clinically available).<br/>It is anticipated that this service will be commissioned under 6 Lots as detailed below. The Hub(s)/TE(s) sites will work with a network of spoke sites. It is anticipated that direct awards will be made to the Spoke sites as part of NHSE existing arrangements with children and young adult cancer PTCs/BMT centres and are thus not identified as a separate Lot. Providers can express interest in one, multiple or all Lots, depending on their capability and capacity: The Fertility Service is a National Service and Providers who express interest in individual lots must demonstrate how they will work with other Providers to ensure equity of access and quality of service across England. <br/>•\tLot 1 – Hub covering North West, North East, Yorkshire & Humber and the Midlands NHS Regions<br/>•\tLot 2 – Hub covering East of England, London, South East and South West NHS Regions<br/>•\tLot 3 – Tissue Establishment covering North West, North East, Yorkshire & Humber Regions and the Midlands NHS Regions <br/>•\tLot 4 Tissue Establishment covering East of England, London, South East and South West Regions <br/>•\tLot 5 – Fertility and Endocrine Restoration Services covering North West, North East, Yorkshire and Humber and Midlands NHS Regions<br/>•\tLot 6 Fertility and Endocrine Restoration Services covering East of England, London, South East and South West NHS Regions",
    "communication": {
      "atypicalToolUrl": "https://health-family.force.com/s/Welcome",
      "futureNoticeDate": "2024-05-20T00:00:00+01:00"
    },
    "classification": {
      "id": "85000000",
      "scheme": "CPV",
      "description": "Health and social work services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-FTS-67205",
      "name": "NHS England",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKE",
        "locality": "Leeds",
        "postalCode": "LS2 7UE",
        "countryName": "United Kingdom",
        "streetAddress": "1st Floor, Quarry House, Quarry Hill"
      },
      "details": {
        "url": "https://www.england.nhs.uk//",
        "buyerProfile": "https://www.england.nhs.uk//",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "legalName": "NHS England"
      },
      "contactPoint": {
        "name": "Anna Salt",
        "email": "anna.salt@nhs.net"
      }
    }
  ],
  "language": "en",
  "description": "There are three service specifications that describe an integrated single fertility preservation and restoration service.  The link to the service specifications is here: NHS England » Service specifications: fertility preservation and restoration <br/><br/>This notice is to advise prospective providers in the market of the commissioner’s intention to commission this service. The outcome of this market engagement will help inform commissioners of the current and future capacity and capability of the market and will be considered with other evidence to inform the commissioning approach. It is possible that as a result of this exercise, a formal tender process may not be required but instead a simpler provider selection process will be undertaken. Where it is noted that competition is absent in any of the Lots, direct awards may be considered. All providers will be notified of next steps following the conclusion of this market engagement exercise. An assurance process may be required if a direct award is recommended.<br/><br/>It is anticipated that the contract duration for this service will be 5 years, including an option to extend for an additional 5 years.",
  "initiationType": "tender"
}